drugset / Trial / NCT04591028

A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer Patients

NCT04591028

Phase 4 Withdrawn Mayo Clinic
NaSingle-groupOpen-labelDiagnostic

Summary

This study will be looking at the safety and added benefit of using the Indocyanine green dye (ICG) during surgery.

Timeline

Start
2022-01
Primary completion
2022-01
Completion
2022-08-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent

Indications